The cautionary advice follows reflections on how Theranos founder Elizabeth Holmes leveraged informal funding practices to gather hundreds of millions of dollars without delivering verifiable diagnostic technology. A recent documentary reveals that Holmes pursued a new healthcare venture dubbed "Theranos 2.0" that reportedly raised around $20 million prior to her prison sentence. Due diligence is becoming harder as superficial artificial intelligence wrappers mask a lack of genuine innovation. Experts insist rigorous verification is critical to prevent dangerous market deceptions.
Key points
Unprofitable technology companies are securing massive valuations despite significant dif…: Unprofitable technology companies are securing massive valuations despite significant difficulties in conducting thorough due diligence.
Handing over massive amounts of venture capital without rigorous proof grants founders da…: Handing over massive amounts of venture capital without rigorous proof grants founders dangerous levels of corporate power.
Investors risk falling victim to fraud if they fail to demand strict technical verificati…: Investors risk falling victim to fraud if they fail to demand strict technical verification during current market booms.
Sources checked by our analysis pipeline: 1
“You Can See Everything,” the documentary capturing disgraced Theranos founder Elizabeth Holmes’ final weeks before prison, is sparking national conversation as it becomes one of the highest-grossing documentaries of all time. The film, directed by Nathan Fielder and Lance Oppenheim, intentionally refuses to characterize Holmes as a master manipulator or victim, instead highlighting her uncanny, almost hypnotic knack for making people pity her, even when they’re well aware of her crimes.
Tyler Shultz didn’t need to see “You Can See Everything” to make up his mind about Holmes. Shultz, whose first job out of college was at Theranos, was a key whistleblower who exposed the company’s dangerously inaccurate blood testing devices, which made their way into Walgreens stores and delivered faulty results to real patients. (Theranos reached a peak valuation of around $10 billion despite its technology never actually working — the company only used its own machines for a fraction of tests, instead outsourcing others to third-party equipment.)
There is little reason to keep talking about Holmes — her case is closed, and she’s in federal prison — but…
Enterprise software giant Salesforce is bolstering its presence in the national security sector by absorbing specialized defense technology. The purchase integrates targeted artificial intelligence solutions designed specifically to manage complex military logistics operations. This strategy directly fuels the development of Salesforce's dedicated defense arm, which was established just twelve months ago.
The retail and cloud computing giant is committing massive capital resources to secure critical components for its next-generation computational infrastructure. This initiative directs substantial capital toward supply chain partners to support expanding artificial intelligence hardware requirements. The dedicated funding effort demonstrates the immense financial scale necessary to maintain advanced manufacturing pipelines in the tech sector.
Developers have compiled an operational 6502 central processing unit directly into a language model framework, bypassing the standard machine learning training pipeline entirely. By converting architectural logic into a neural network's internal states, the system faithfully replicates original gaming hardware through token prediction. This technical achievement demonstrates an unconventional method for repurposing transformer parameters to execute deterministic computing workloads.